---

PFAS: Cardiovascular Risk, Atherosclerosis, Sources, Prevention & Dairy Packaging

---

What Are PFAS?

---

Risk of Myocardial Infarction (MI)

Epidemiological Evidence

• Multiethnic Study of Atherosclerosis (MESA): Higher serum PFAS (particularly PFOS and PFOA) were associated with increased subclinical cardiovascular disease markers.
• C8 Health Project (>69,000 residents near a DuPont plant, West Virginia): Elevated PFOA exposure was significantly associated with higher rates of coronary artery disease and MI.
• NHANES analyses: Consistently show dose-response associations between PFAS quartiles and self-reported coronary heart disease.
• A 2023 meta-analysis (Environment International) pooling >15 cohort studies found a ~20–30% increased relative risk of CVD events (including MI) in the highest vs. lowest PFAS exposure quintiles.

Biological Mechanisms for MI

---

PFAS and Atherosclerosis

1. Lipid Dysregulation

• PFAS are structurally similar to fatty acids and bind to lipid-transport proteins (albumin, liver fatty acid-binding protein).
• They activate PPARα in the liver → increased VLDL and LDL production.
• PFOA and PFOS consistently raise total cholesterol by 10–15 mg/dL per unit increase in serum concentration (documented in both adult and pediatric cohorts).

2. Vascular Inflammation

• Macrophage activation → foam cell formation → plaque initiation.
• PFAS upregulate VCAM-1 and ICAM-1 on endothelium, promoting monocyte adhesion.

3. Direct Vascular Toxicity

• PFAS impair mitochondrial function in endothelial cells.
• Animal studies show accelerated aortic plaque formation with PFOS/PFOA exposure at environmentally relevant doses.

4. Hypertension (independent risk factor for atherosclerosis)

• Meta-analyses show PFOA/PFOS correlate with a ~2–5 mmHg increase in systolic BP.
• Particularly significant in pregnancy (preeclampsia risk) and pediatric hypertension.

5. Thyroid Disruption

• PFAS compete with thyroid hormones for binding to thyroid-binding globulin → hypothyroid-like state → dyslipidemia and atherosclerosis.

---

Sources of PFAS Exposure

Dietary (Primary Route — ~70–90% of exposure for most people)

Non-Dietary

---

Dairy Milk in Tetra Pak Cartons and PFAS

The Issue

Key Findings

• Migration studies (European Food Safety Authority, 2020–2023): PFAS can migrate from food-contact materials into liquid contents, especially under prolonged storage and higher temperatures.
• A 2023 Danish study (Technical University of Denmark) found measurable PFAS (including PFOA, PFHxS) in milk stored in cartons, with migration increasing over storage time.
• Fluorinated paperboard: Some carton inner liners contain per- and polyfluorinated compounds as processing aids; even trace amounts can migrate into fatty matrices like whole milk.
• A U.S. FDA study (2022) identified PFAS migration from food packaging into dairy products, with full-fat milk showing higher PFAS concentrations than skim milk — consistent with PFAS lipophilicity.
• Tetra Pak's response: The company has stated it does not intentionally add PFAS to its primary packaging layers, but contamination from recycled paperboard or processing aids in upstream supply chains remains documented.

Relative Risk

• PFAS levels in carton-packaged dairy are generally in the low ppt (ng/L) range.
• Compared to contaminated drinking water sources or fast food packaging, carton dairy is a moderate contributor.
• Children who consume large volumes of whole milk from cartons are the most exposed sub-group by this route.
• Glass-bottled or plastic (HDPE) alternatives have lower documented PFAS migration.

---

Prevention and Exposure Reduction

Dietary Modifications

Kitchen Practices

• Replace non-stick cookware (PTFE/Teflon) with cast iron, stainless steel, or ceramic — particularly if scratched or used at high heat.
• Do not use polytetrafluoroethylene-lined air fryer baskets at high settings.
• Store food in glass or stainless steel rather than coated cardboard containers.

Household

• Vacuum frequently with HEPA-filter vacuums (reduces PFAS-laden dust ingestion, especially for children).
• Avoid stain-treating carpets and upholstery with fluorinated products (e.g., Scotchgard with PFAS).
• Choose PFAS-free outdoor and waterproof gear (brands certified under bluesign or PFC-free DWR).

For Dairy Specifically

• Glass-bottled milk (where available) represents the lowest PFAS-from-packaging risk.
• HDPE (high-density polyethylene) plastic jugs are a lower-risk alternative to cartons.
• Organic certification does not guarantee PFAS-free dairy — contamination depends on farm location and water/soil quality, not farming method.
• Limiting high-fat dairy (butter, heavy cream) reduces lipophilic PFAS load, as PFAS concentrate in fat fractions.

Medical/Clinical

• No approved PFAS chelation therapy exists currently.
• Cholestyramine (bile acid sequestrant) and activated charcoal have been studied to interrupt enterohepatic recirculation of PFAS — limited and inconsistent evidence.
• Cholesterol management: Given PFAS-driven dyslipidemia, statins may be particularly relevant in highly exposed individuals.
• Regular BP monitoring and aggressive treatment of hypertension in exposed individuals.
• Ongoing biomonitoring: CDC NHANES programs track national serum PFAS levels; individual testing is available via commercial labs (Quest, LabCorp).
• The NIH PFAS Health Study and ATSDR PFAS multi-site study continue to enroll participants from contaminated communities.

---

Regulatory Landscape (2024–2025)

---

Summary

• PFAS are ubiquitous, persistent cardiovascular toxins with strong epidemiological evidence for increased MI risk (~20–30% elevated relative risk) and accelerated atherosclerosis via dyslipidemia, inflammation, hypertension, and endothelial dysfunction.
• Dietary exposure dominates, with drinking water, fast food packaging, and certain dairy products (particularly full-fat milk in cartons) as key contributors.
• Tetra Pak cartons can leach low but measurable levels of PFAS into milk, especially whole milk stored over time; glass or HDPE containers are safer alternatives.
• Prevention is primarily avoidance-based — water filtration, cookware replacement, packaging choices, and dietary modifications are the most evidence-backed interventions.
• No definitive medical treatment exists to accelerate PFAS elimination; aggressive management of PFAS-associated cardiovascular risk factors (lipids, BP) is the current clinical standard.